A federal lawsuit is accusing three of the biggest drug manufacturers of insulin of conspiring together to raise their prices, but the pharmaceutical companies deny the allegations. The lawsuit, filed on in January in a federal court in Massachusetts, said Sanofi SA, Novo Nordisk and Eli Lilly & Co simultaneously hiked the price of the drug. Investment research firm SSR Health analyzed list …